Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2014

Aug 15, 2014

30718_dirs_2014-08-15_3dd403bf-a00b-4866-93b0-641182fc3dbb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2014-08-14

Reporting Person: HOLBROOK KAREN A (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-08-14 Common Stock M 5000 $57.06 Acquired 6000 Direct
2014-08-14 Common Stock S 5000 $95.54 Disposed 1000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-08-14 Stock Option $57.06 M 5000 Disposed 2017-02-11 Common Stock (5000) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $87.39 2023-10-30 Common Stock (4000) 4000 Direct
Stock Option $66.9 2022-10-24 Common Stock (5000) 5000 Direct
Stock Option $70.35 2021-10-26 Common Stock (5000) 5000 Direct
Stock Option $61.46 2020-10-27 Common Stock (5000) 5000 Direct
Stock Option $63.03 2019-10-28 Common Stock (5000) 5000 Direct
Stock Option $65.47 2018-10-22 Common Stock (5000) 5000 Direct
Stock Option $66.59 2017-10-24 Common Stock (5000) 5000 Direct